VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $220,556 | -6.9% | 7,325 | 0.0% | 0.10% | -6.8% |
| Q1 2023 | $236,964 | +12.9% | 7,325 | 0.0% | 0.10% | +17.0% |
| Q4 2022 | $209,934 | +2.4% | 7,325 | -2.0% | 0.09% | 0.0% |
| Q2 2022 | $205,000 | -28.3% | 7,475 | 0.0% | 0.09% | -33.8% |
| Q1 2022 | $286,000 | +19.7% | 7,475 | 0.0% | 0.13% | +15.7% |
| Q4 2021 | $239,000 | +5.3% | 7,475 | -3.2% | 0.12% | -2.5% |
| Q3 2021 | $227,000 | -11.7% | 7,725 | +2.0% | 0.12% | -15.7% |
| Q2 2021 | $257,000 | +4.5% | 7,575 | 0.0% | 0.14% | -4.1% |
| Q1 2021 | $246,000 | -8.6% | 7,575 | +1.3% | 0.15% | -18.4% |
| Q4 2020 | $269,000 | -4.3% | 7,475 | +4.2% | 0.18% | -18.6% |
| Q3 2020 | $281,000 | – | 7,175 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |